LadRx Corporation (LADX)
OTCMKTS · Delayed Price · Currency is USD
0.0500
+0.0400 (400.00%)
Mar 12, 2026, 9:30 AM EST
LadRx Market Cap
LadRx has a market cap or net worth of $25.25 thousand as of March 13, 2026. Its market cap has decreased by -97.32% in one year.
Market Cap
25.25K
Enterprise Value
-181.70K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since April 5, 1988, LadRx's market cap has decreased from 83.03M to 25.25K, a decrease of -99.97%. That is a compound annual growth rate of -19.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 25.25K | 363.64% |
| Dec 29, 2025 | 5.45K | -99.35% |
| Dec 31, 2024 | 831.76K | 29.23% |
| Dec 29, 2023 | 643.62K | -87.57% |
| Dec 30, 2022 | 5.18M | -73.55% |
| Dec 31, 2021 | 19.58M | -69.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Therapeutic Solutions International | 7.05K |
| NovAccess Global | 6.19K |
| Theralink Technologies | 6.15K |
| Hard to Treat Diseases | 5.82K |
| FluoroPharma Medical | 5.52K |
| Syros Pharmaceuticals | 5.37K |
| MultiCell Technologies | 5.00K |
| Kaleido Biosciences | 4.26K |